financetom
Business
financetom
/
Business
/
Panama to review all information to make an informed First Quantum decision
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Panama to review all information to make an informed First Quantum decision
Jul 2, 2024 4:17 PM

PANAMA CITY, July 2 (Reuters) - Panama's government will

review and analyze all the available information to make an

"informed and responsible decision" regarding new President Jose

Raul Mulino's request for an environmental audit of Canadian

miner First Quantum Minerals' ( FQVLF ) Cobre Panama mine.

"In his message to the nation, President Mulino said he will

order a strict environmental audit; So for our part, we are

going to review and analyze all the information available to

make informed and responsible decision," Trade and Industry

Minister Julio Molto told Reuters on Tuesday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Novabay Pharmaceuticals Signs Definitive Agreement To Sell Its Avenova Assets
BRIEF-Novabay Pharmaceuticals Signs Definitive Agreement To Sell Its Avenova Assets
Sep 22, 2024
Sept 20 (Reuters) - NovaBay Pharmaceuticals Inc ( NBY ): * NOVABAY PHARMACEUTICALS SIGNS DEFINITIVE AGREEMENT TO SELL ITS AVENOVA ASSETS * NOVABAY PHARMACEUTICALS INC ( NBY ) - TO SELL AVENOVA ASSETS TO PRN FOR $9.5 MILLION Source text for Eikon: Further company coverage: ...
Merck Receives Positive EU CHMP Opinions for Keytruda in Gynecologic Cancers
Merck Receives Positive EU CHMP Opinions for Keytruda in Gynecologic Cancers
Sep 22, 2024
08:17 AM EDT, 09/20/2024 (MT Newswires) -- Merck ( MRK ) said Friday that it has received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use for its anti-PD-1 therapy Keytruda in two gynecologic cancer indications. The first opinion recommends Keytruda with carboplatin and paclitaxel as first-line treatment of advanced or recurrent endometrial carcinoma, while...
NIO Denies Audi Plant Takeover Rumors: Report
NIO Denies Audi Plant Takeover Rumors: Report
Sep 22, 2024
NIO Inc. ( NIO ) shares are trading relatively flat in the premarket session on Friday. The Chinese EV maker has denied rumors about plans to take over the Audi Brussels car plant in Vorst, reported CnEV Post. Yesterday, NIO was in the headlines after media reports emerged that the NIO delegation visited the Vorst plant in recent weeks and...
Regeneron, Sanofi Say Eosinophilic Esophagitis Drug Recommended for Children in EU
Regeneron, Sanofi Say Eosinophilic Esophagitis Drug Recommended for Children in EU
Sep 22, 2024
08:26 AM EDT, 09/20/2024 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) and Sanofi ( SNY ) said Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use recommended the expanded approval of its eosinophilic esophagitis drug Dupixent to treat children 1 to 11 years old. Dupixent, a human monoclonal antibody developed using Regeneron's VelocImmune technology, is...
Copyright 2023-2026 - www.financetom.com All Rights Reserved